Fig. 7From: Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapyThe binding mode of BMS-116 with IDO1 (PDB code: 6AZW). The inhibitor BMS-116 is displayed in yellow stick. The H-bonding interaction is indicated by the blue dotted linesBack to article page